News and Announcements
From Child to Citizen of the Family Enterprise: The Five Act Family Drama of Next Generation Development
- Published September 25, 2012 9:18AM UTC
- Publisher Wholesale Investor
- Categories Capital Insights
By: Dennis T. Jaffe
Dennis T. Jaffe examines the unique challenges that wealthy families face in raising their children as well-adjusted individuals, productive members of their family enterprises and responsible members of the society at large. To this end, Mr. Jaffe details a five stage plan that begins in the child’s first years with basic instruction about money and builds on this framework with successive stages that culminate with the child’s being accepted as a full family citizen and future leader. With this process completed, the family has taken a major step in insuring the family’s continued legacy through another generation.
To read a full article, please download a document below.
Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
